Skip to content

Clinical trials

Cardiomyopathy, Hypertrophic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Hypertrophic Country / region: Italy Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20161
20185
20193
20201
20212
20223
20234
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting7
Active, not recruiting5
Terminated3
Unknown status3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
Cytokinetics4
Centro Cardiologico Monzino2
Fatebenefratelli Hospital2
IRCCS Azienda Ospedaliero-Universitaria di Bologna2
Michele De Bonis2
Centro Medico Teknon1
Gilead Sciences1
IRCCS San Raffaele1
Imbria Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Hypertrophic28
Heart Failure4
Cardiomyopathies3
Cardiomyopathy, Dilated3
Fabry Disease3
Amyloid Neuropathies, Familial2
Coronary Artery Disease2
Death, Sudden, Cardiac2
Angina Pectoris1
Aortic Valve Disease1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.